Table 1.
Characteristics of women by reconstruction type, n (%) or median (min–max).
| Characteristics | Autologous n = 47 | Implant n = 47 | |
|---|---|---|---|
| Age at mastectomy | 45.0 (31–72) | 42.0 (21–59) | |
| Age at reconstruction | 49.0 (31–74) | 42.0 (22–59) | |
| Age at questionnaires completed | 51.0 (35–78) | 44.0 (26–62) | |
| Interval (months) between mastectomy and the first reconstruction | 21.0 (0–135) | 45.0 (0 to 90) | |
| Interval (months) between the last reconstruction and questionnaire completion | 26.0 (5–52) | 23.5 (4–48) | |
| Comorbidity * | 11 (23.4%) | 6 (12.8%) | |
| BMI at time of surgery | 26.0 (20–33) | 23.0 (18–34) | |
| BMI >30 kg/m2 | 10 (22.2%) | 2 (4.3%) | |
| Smoking | 7 (14.9%) | 14 (30.4%) | |
| Chemotherapy | 23 (48.9%) | 13 (30.2%) | |
| Radiotherapy | 20 (42.6%) | 6 (12.8%) | |
| Mastectomy | Unilateral | 33 (70.2%) | 16 (34.0%) |
| Bilateral | 14 (29.8%) | 31 (66.0%) | |
| Reconstruction: | Unilateral | 34 (72.3%) | 15 (31.9%) |
| Bilateral | 13 (27.7%) | 32 (68.1%) | |
| TNM staging | Stadium 0–IIB | 25 (71.4%) | 23 (92.0%) |
| Stadium IIIA–IIIC | 10 (28.6%) | 2 (8.0%) | |
| BRCA1 or BRCA2 positive | 9 (19.1%) | 28 (59.6%) | |
| Reconstruction: | Primary | 17 (36.2%) | 29 (61.7%) |
| Secondary | 30 (63.8%) | 18 (38.3%) | |
| Nipple reconstruction | 32 (68.1%) | 24 (51.1%) | |
| Areola tattoo | 26 (55.3%) | 16 (34.0%) | |
| Education: | Low | 35 (74.5%) | 22 (48.9%) |
| High | 12 (25.5%) | 23 (51.1%) | |
| Partner at time of questionnaire | Single | 7 (15.2%) | 7 (15.2%) |
| Partner | 39 (84.8%) | 39 (84.8%) | |
Abbreviations: BMI = body mass index; BRCA1 = BRCA1, DNA repair associated gene; BRCA2 = BRCA2, DNA repair associated gene; TNM = TNM Classification of Malignant Tumors; data are condensed and divided into two categories: Stage 0 - IIB "and" Stage III – IIIC.
⁎
Including: diabetes mellitus, fibromyalgia, hypertension, and psychological instability.